Business
Axxess Pharma has a Portfolio of Products to Market; Analyst Report by SmallCapIR and Issued by BrokerBank Securities, Inc.
Axxess Pharma has a Portfolio of Products to Market; Analyst Report by SmallCapIR and Issued by BrokerBank Securities, Inc..
About this update from Allstar Health Brands, Inc.
[{"type":"text","content":"\n\n\n\nAxxess Pharma has a Portfolio of Products to Market; Analyst Report by SmallCapIR and Issued by BrokerBank Securities, Inc.\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAxxess Pharma has a Portfolio of Products to Market; Analyst Report by SmallCapIR and Issued by BrokerBank Securities, Inc.\nPR Newswire\nNEW YORK, Aug. 13, 2014\n\n\n\nNEW YORK, Aug. 13, 2014 /PRNewswire/ -- Axxess Pharma, Inc. (OTCBB: AXXE) offers products targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. \n\nThe company has acquired the assets necessary to distribute all of the TAPOUT products line of muscle enhancement line and a complete line of nutraceuticals.\n\nWith a plethora of products to market many investors are now waiting to see the revenues. To learn more about the revenue potential a full report on AXXE that includes, potential revenues, and review of current business model, management and analyst summary, can be viewed by using the following link:\n\nhttp://bit.ly/-AXXE-AnalystReport\n\nCopy and paste to browser may be required.\n\nAbout SmallCapIR\n\nOnce you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.\n\nOur Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.\n\nForward-Looking Disclaimer    \n\nThis report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to th...